KRAS and familial pancreatic carcinoma: Besides, recent research demonstrated that exosomes could directly and specifically target the oncogenic KRAS, which is also an essential gene in the development of pancreatic cancer, this made exosomes to be the best novel therapeutic candidates for pancreatic cancer [26].